Another exciting clinical update on Zelenectide
Today during #SABCS24, we announced data updates for zelenectide pevedotin in #breastcancer, #lungcancer and #bladdercancer. Join our investor call tomorrow at 8 a.m. ET where we’ll review and discuss the data with #oncology experts Sherene Loi and Niklas Klümper. Read more here: https://bit.ly/41wjLWv.
⏰ Countdown Alert! Just 2 days until Sheila D. Walcoff, JD, unpacks the FDA's Final Rule for Oncology LDTs at 1 PM ET. Whether you're a seasoned pro or just starting to navigate the complexities of cancer lab regulations, this session is a must-attend. Secure your spot, sharpen your knowledge, and stay ahead of the curve! 🔗 Join the webinar: https://bit.ly/3YFFI3U 🤝 Today's Clinical Lab #LDT #FDA #Oncology #CancerDiagnosis
🚨 Time’s almost up! In just 2 days, at 1 PM ET, Sheila D. Walcoff, JD, is diving into the complexities of the FDA's Final Rule for Oncology LDTs. Don’t miss out on this vital session where you'll gain the insights needed to steer your cancer lab through the latest regulations. Get your spot now and be ready to navigate the future with confidence! 🧬💼 🔗 Join the webinar: https://bit.ly/3YFFI3U 🤝 G2 Intelligence #LDT #FDA #Oncology #CancerDiagnosis
In this episode of #OncLiveOnAir, Dr Sekeres, of Sylvester Comprehensive Cancer Center, discusses the significance of the FDA approval of imetelstat for patients with lower-risk #MDS and transfusion-dependent anemia. https://lnkd.in/eyDYzd8e
🚨 Upcoming Webinar Alert! 🚨 Join us live on September 5th at 1 PM EST as Sheila D. Walcoff, JD, breaks down how cancer labs can navigate the FDA's final rule on oncology LDTs. If you're in the field, this is a must-attend event to ensure your lab stays compliant and ahead of the curve. 🔗 Save your spot now: https://bit.ly/3YFFI3U #CancerResearch #Oncology #ClinicalLabs #WebinarAlert #LabCompliance
Get ready for an exciting week of discussions on the latest healthcare innovations, data intelligence, and oncology insights as our CEO Bruno Larvol is attending the HLTH USA Event 2024 in Las Vegas, NV from October 20-23, 2024! ✨ Stay tuned for insights and updates from the event as LARVOL continues to drive #OncologyDataIntelligence forward. See you at #HLTHUSA 2024! #LARVOL #Oncology #CancerResearch #CancerData #HealthcareInnovation #DigitalHealth #OncologyUpdates
📺 Watch part 3 of the ADCs in UC panel from #UromigosLive24, which focused on the use of HER2 ADCs in #bladdercancer, including various trials on disitamab vedotin and trastuzumab deruxtecan:
🚨 Upcoming Webinar Alert! 🚨 Join us live on September 5th at 1 PM EST as Sheila D. Walcoff, JD, breaks down how cancer labs can navigate the FDA's final rule on oncology LDTs. If you're in the field, this is a must-attend event to ensure your lab stays compliant and ahead of the curve. 🔗 Save your spot now: https://bit.ly/3YFFI3U #CancerResearch #Oncology #ClinicalLabs #WebinarAlert #LabCompliance
Each clinical trial is different, and so is every LabConnect solution. Here are just a few examples of how our tailored approach accelerates oncology trial milestones.
Oncology trial complexity? Our FSP Solutions Team can help. LabConnect’s scientific experts overcome global analytical challenges. Download the case study to learn about our cure for the uncommon trial => https://lnkd.in/ggrzd5G6 #Oncology #ClinicalTrial #CentralLab #A4P
Oncoinfluencers to Follow on Social Media: Dr. Sunil Verma AstraZeneca https://lnkd.in/epTKAfRc #Cancer #Oncologist #AstraZeneca #BCSM #LCSM #CancerResearch #OncoDaily #Oncology #OncoInfluencer
